Your browser doesn't support javascript.
loading
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
Lassman, Andrew B; van den Bent, Martin J; Gan, Hui K; Reardon, David A; Kumthekar, Priya; Butowski, Nicholas; Lwin, Zarnie; Mikkelsen, Tom; Nabors, Louis B; Papadopoulos, Kyriakos P; Penas-Prado, Marta; Simes, John; Wheeler, Helen; Walbert, Tobias; Scott, Andrew M; Gomez, Erica; Lee, Ho-Jin; Roberts-Rapp, Lisa; Xiong, Hao; Ansell, Peter J; Bain, Earle; Holen, Kyle D; Maag, David; Merrell, Ryan.
Afiliação
  • Lassman AB; Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • van den Bent MJ; Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Gan HK; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
  • Reardon DA; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Kumthekar P; Austin Health and Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Butowski N; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lwin Z; Northwestern University, Chicago, Illinois, USA.
  • Mikkelsen T; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
  • Nabors LB; Department of Medical Oncology, University of Queensland School of Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Papadopoulos KP; Henry Ford Health System, Detroit, Michigan, USA.
  • Penas-Prado M; University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Simes J; South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, USA.
  • Wheeler H; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Walbert T; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Scott AM; Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Gomez E; Henry Ford Health System, Detroit, Michigan, USA.
  • Lee HJ; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
  • Roberts-Rapp L; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Xiong H; Austin Health and Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Ansell PJ; AbbVie Inc., North Chicago, Illinois, USA.
  • Bain E; AbbVie Inc., North Chicago, Illinois, USA.
  • Holen KD; AbbVie Inc., North Chicago, Illinois, USA.
  • Maag D; AbbVie Inc., North Chicago, Illinois, USA.
  • Merrell R; AbbVie Inc., North Chicago, Illinois, USA.
Neuro Oncol ; 21(1): 106-114, 2019 01 01.
Article em En | MEDLINE | ID: mdl-29982805
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Amplificação de Genes / Glioblastoma / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Amplificação de Genes / Glioblastoma / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido